Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Aug 28, 2026

MENS — Jyong Biotech Ltd. Dilution Risk Tracker

Track MENS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MENS — Get alerts when the score changes →

As of August 28, 2026, Jyong Biotech Ltd. (MENS) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Jyong Biotech Ltd. has a market capitalization of $167.26M, 76.03M shares outstanding, 17 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
57
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔄 Reverse Split model est. 15%
• Only 5 months cash — financial pressure
🔔 Track MENS — Get forecast alerts →

Market Data

Market Cap$167.26M
Shares Outstanding76.03M
Float26.94M
Cash$1.18M
Debt$17.46M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 29.9% shares (2026Q1 vs prior)
17 institutional holders · 484.6K shares
#1 BlackRock, Inc. 258.8K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 64.2K shares
#3 UBS Group AG 37.4K shares
+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest179.8K
Days to Cover3.0
% of Float0.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track MENS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MENS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MENS
MENS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.